Cargando…
microRNA-660 Enhances Cisplatin Sensitivity via Decreasing SATB2 Expression in Lung Adenocarcinoma
Increasing evidence suggests that microRNAs’ (miRNAs) abnormal expression is one of the main factors of chemotherapy resistance in various cancers. However, the role of miRNAs in lung adenocarcinoma (LUAD) resistance to cisplatin is still unclear. In this study, we analyzed a microarray dataset to i...
Autores principales: | Wang, Ziyao, Zhou, Lingxuan, Chen, Bisong, Li, Xu, Zou, Qiuyi, Xu, Wei, Fang, Li, Wu, Anbang, Li, Zheng, Chen, Yuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137726/ https://www.ncbi.nlm.nih.gov/pubmed/37107669 http://dx.doi.org/10.3390/genes14040911 |
Ejemplares similares
-
Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin
por: Li, Ning, et al.
Publicado: (2019) -
Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
por: Elebro, Jacob, et al.
Publicado: (2014) -
MicroRNA-191 triggers keratinocytes senescence by SATB1 and CDK6 downregulation
por: Lena, A.M., et al.
Publicado: (2012) -
Interplay of MicroRNA-21 and SATB1 in Epidermal Keratinocytes during Skin Aging
por: Ahmed, Mohammed I., et al.
Publicado: (2019) -
Genomic Analysis of the Serratia marcescens Bacteriophage BUCT660
por: Li, Yahao, et al.
Publicado: (2022)